eXciteOSA® Device

** NEW PRODUCT!!!! **

eXciteOSA® – A Daytime Therapy For Mild Obstructive Sleep Apnea and Snoring! eXciteOSA® therapy is the only FDA-authorized, clinically proven daytime therapy for mild obstructive sleep apnea (OSA) and snoring. eXciteOSA® targets the root cause of mild OSA and snoring rather than relieving the symptoms.

About the Therapy:

eXciteOSA® improves the muscle function of the tongue through stimulation therapy. Improvement of muscle function prevents the upper airway tissue from collapsing and ensures that the upper airway remains open during sleep, thereby improving sleep quality. eXciteOSA® is currently available by prescription only in the United States.

How eXciteOSA® Works:

eXciteOSA® is used for 20 minutes, one time a day for 6 weeks, and only twice per week thereafter. It’s clinically proven to reduce mild obstructive sleep apnea and snoring significantly. (a), (b), (c). The eXciteOSA® device is convenient and simple to use:

1. The mouthpiece gets positioned onto your tongue.

2. The app activates and customizes each therapy session, making this experience unique to you.

3. The app tracks your progress and keeps you focused on therapy goals

Key Clinical Results: eXciteOSA® offers a convenient daytime therapy for noticeable night-time results:

• 90% of patients reported a reduction in snoring time (c)

• 89% of bed partners reported a reduction of their partners snoring (c)

• 79% of sleep apnea patients achieved a reduction in sleep apnea measures (c) 

At Performance Home Medical, we are committed to your treatment's success. As an eXcite OSA patient, you will be given a complimentary 15-minute instruction appointment with a member from our clinical team. This can be completed in person or virtually. Please contact us today to schedule this visit!

REFERENCES: (a) E.Wessoleck et al. Intraoral electrical muscle stimulation in the treatment of snoring. Somnologie (Berl). 2018; 22(Suppl 2): 47–52. (b) A.Sama et al. Daytime Intraoral Neurostimulation with Snoozeal® for treatment of Snoring and Mild Sleep Apnea. CHEST Annual Meeting Notes, 2018. (c) eXciteOSA® White Paper (2020). Clinical study of 115 patients with snoring or mild OSA (Apnea- Hypopnea Index (AHI) <15 n=65) completed the trial. Objective snoring and respiratory parameters were recorded with 2 consecutive WatchPAT® night sleep studies before and after the use of the device. An intra-oral tongue stimulator device was used for 20 mins, once a day for 6-week period. (Internal publication by SMT for educational purposes and submission.)